Pfizer will not make future investments in Russia but stops short of severing all business ties, Bourla says

While many corporations have ended their ties to Russia as it continues to wage war on Ukraine, Big Pharma has been largely absent from its ranks. That changed — slightly — on Wednesday with a new declaration from Pfizer CEO Albert Bourla.

Speaking on CBS’ Face the Nation program Wednesday, Bourla said Pfizer will end plans for future investment in Russia while not cutting ties completely. Bourla argued that Pfizer still needs to provide Russian patients with lifesaving drugs, regardless of their government’s actions.